Loading...

ImmunoGen, Inc.

IMGNNASDAQ
Healthcare
Biotechnology
$31.23
$0.005(0.02%)

ImmunoGen, Inc. IMGN Peers

See (IMGN) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
IMGN$31.24+0.02%8.7B-111.55-$0.28N/A
VRTX$459.62+0.57%118B-119.69-$3.84N/A
REGN$547.36-0.07%58.1B13.91$39.35+0.16%
ALNY$331.91+0.65%43.3B-157.30-$2.11N/A
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ARGX$543.48-0.30%33.2B33.16$16.39N/A
BNTX$110.00+1.61%26.4B-30.05-$3.66N/A
RPRX$36.37+0.50%20.5B14.84$2.45+2.36%
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
DNA-WT$0.27-2.76%18.7BN/AN/AN/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

IMGN vs VRTX Comparison

IMGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMGN stands at 8.7B. In comparison, VRTX has a market cap of 118B. Regarding current trading prices, IMGN is priced at $31.24, while VRTX trades at $459.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMGN currently has a P/E ratio of -111.55, whereas VRTX's P/E ratio is -119.69. In terms of profitability, IMGN's ROE is -1.43%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, IMGN is less volatile compared to VRTX. This indicates potentially lower risk in terms of short-term price fluctuations for IMGN.

Stock Price Comparison

Loading...

Frequently Asked Questions

;